Familial clustering of prostate cancers was reported and ~5% of cases of prostate cancer could be directly related to highly penetrant mutations at the level of BRCA1, BRCA2, and HOXB13 [715]. This evidence concerns the gene BRCA1 and prostate carcinoma.